Maupali Dasgupta

Maupali Dasgupta, PhD, has had extensive work experience in the scientific and medical writing field. Maupali is currently working as the Scientific Director at Lockwood since October 2020. Prior to this role, they were a Senior Medical Writer at Envision Pharma Group from December 2017 to October 2020. Before that, they worked as a Medical Writer at Fishawack Group of Companies from September 2016 to November 2017. Prior to entering the medical writing field, they started their career as a Scientific Associate at ProEd Communications from November 2014 to August 2016. Maupali also served as a Post-Doctoral Researcher at Cleveland Clinic from January 2008 to September 2014.

Maupali Dasgupta, PhD, has an extensive education history. Maupali obtained their Bachelor of Science (BS) degree in Chemistry from the University of Calcutta. Maupali then went on to pursue a Master's degree in Biochemistry and Molecular Biology from the same institution.

In 2000, Dasgupta continued their education at the University of Iowa, although the specific degree and field of study are not provided.

Maupali'sacademic journey culminated with a Ph.D. in Cell and Molecular Biology from Kent State University, where they studied from 2001 to 2007.

In addition to their formal education, Dasgupta obtained a Certificate in Regulation of Pharmaceutical Products from the Regulatory Affairs Professional Society (RAPS) in July 2014.